Skip to main content
Article
Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma
Annals of the New York Academy of Sciences (2013)
  • Jedd D. Wolchok, Memorial Sloan Kettering Cancer Center
  • F. Stephen Hodi, Harvard University
  • Jeffrey S. Weber, University of South Florida
  • James P. Allison, University of Texas MD Anderson Cancer Center
  • Walter J. Urba, Providence Portland Medical Center
  • Caroline Robert, Institut Gustave Roussy
  • Steven J. O'Day, Cancer Institute
  • Axel Hoos, GlaxoSmithKline
  • Rachel Humphrey, Bristol-Myers Squibb
  • David M. Berman, Bristol-Myers Squibb
  • Nils Lonberg, Bristol-Myers Squibb
  • Alan J. Korman, Bristol-Myers Squibb
Publication Date
January 7, 2013
DOI
10.1111/nyas.12180
Citation Information
Jedd D. Wolchok, F. Stephen Hodi, Jeffrey S. Weber, James P. Allison, et al.. "Development of ipilimumab: a novel immunotherapeutic approach for the treatment of advanced melanoma" Annals of the New York Academy of Sciences Vol. 1291 Iss. 1 (2013) p. 1 - 13
Available at: http://works.bepress.com/walter-urba/147/